Dementia associated with scleromyxoedema reversed by high-dose intravenous immunoglobulin
B. Shergill(The Royal Free Hospital), M.H.A. Rustin, Sandy McBride(The Royal Free Hospital), Catherine H. Orteu(Royal Free London NHS Foundation Trust)
Cited by 25
Related Papers
European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes
|Journal of the European Academy of Dermatology and Venereology|2017|262
Interferon‐β mediates stromal cell rescue of T cells from apoptosis
|European Journal of Immunology|1999|199
Fabry disease and the skin: data from FOS, the Fabry outcome survey
|British Journal of Dermatology|2007|178
A deficiency in the in vivo clearance of apoptotic cells is a feature of the NOD mouse
|Journal of Autoimmunity|2006|115
European dermatology forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis
|Journal of the European Academy of Dermatology and Venereology|2017|115